Difference between revisions of "Part:BBa K4242025:Design"
Jiangzhelin (Talk | contribs) (→Design Notes) |
|||
Line 7: | Line 7: | ||
===Design Notes=== | ===Design Notes=== | ||
− | + | We constructed the composite part (BBa_K4242017) to control the intracellular c-di-GMP level in our engineering strain. In that part, the expression of yhjH is controlled by Ptac. To eliminate the effects from other place of the biobrick, we constructed this part and inserted it into the wide-type strain as a control. | |
− | + | ||
− | + | ||
===Source=== | ===Source=== |
Revision as of 01:42, 9 October 2022
pSB3C5-A1
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
We constructed the composite part (BBa_K4242017) to control the intracellular c-di-GMP level in our engineering strain. In that part, the expression of yhjH is controlled by Ptac. To eliminate the effects from other place of the biobrick, we constructed this part and inserted it into the wide-type strain as a control.
Source
We constructed the composite part (BBa_K4242017) to control the intracellular c-di-GMP level in our engineering strain. In that part, the expression of yhjH is controlled by Ptac. To eliminate the effects from other place of the biobrick, we constructed this part and inserted it into the wide-type strain as a control.